Note: Ingredients listed on restricted chemical lists
EC/CAS
204-589-7/122-99-6
Name of the chemical
2-Phenoxyethanol
Concentration
<1
General Information
Version
1.3
Revision date
2023-12-13
Product name
JEECIDE CAP-4
supplier name
Vantage Specialty Ingredients, Inc
Emergency telephone
+1 703-527-3887
Icons in SDS
Company Information
company name
VANTAGE SPECIALTIES SPAIN, S.L.U
e-mail address of the competent person responsible for the Safety Data Sheet
regulatory-techservices@vantagegrp.com, regulatory-techservices@vantagegrp.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H318, H335
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Harmful if swallowed. May cause respiratory irritation. Causes serious eye damage.
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS07
Signal word
Danger
Contains
2-phenoxyethanol
Hazard statements
H302 - Harmful if swallowed. H318 - Causes serious eye damage. H335 - May cause respiratory irritation.
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P271 - Use only outdoors or in a well-ventilated area. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P301+P312 - IF SWALLOWED: Call a POISON CENTRE or doctor if you feel unwell.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Phenoxyethanol (122-99-6), Caprylyl Glycol (1117-86-8) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH Phenoxyethanol (122-99-6), Caprylyl Glycol (1117-86-8) regulation, in accordance with Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %